GUI Workflow Control for Automated Cell Therapy Manufacturing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional cell therapy manufacturing processes are labor-intensive, require skilled technicians, and are challenging to scale due to complex scheduling and handling of sensitive biological materials, leading to inefficiencies and potential human errors.
Innovation Solution
A graphical user interface (GUI) system that allows users to create, modify, and execute workflows for automated cellular therapy manufacturing, utilizing a robotic cluster to perform unit operations through a modular and automated process, reducing human intervention and enhancing scalability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional labor-intensive processes are used for cell therapy manufacturing, then skilled technicians can handle complex operations, but the process requires large numbers of operators and is difficult to scale
Solution Approach 1:
The system enables self-service automation where the robotic cluster independently executes manufacturing workflows without continuous human intervention. The automated system handles sensitive biological materials through programmable sequences, eliminating the need for large numbers of skilled technicians while maintaining handling precision and enabling industrial-scale production.
Solution Approach 2:
Manual mechanical operations performed by skilled technicians are replaced with automated robotic systems. The robotic cluster uses programmable mechanical actions to handle, transfer, and process cell therapy materials, maintaining the precision of human operators while enabling scalable manufacturing through automation.
2Extent of automation
If biological foundries are used to automate manufacturing, then labor intensity is reduced, but scheduling conflicts arise when multiple processes need the same instrument
Solution Approach 1:
The robotic cluster is designed as a universal platform capable of performing multiple different unit operations across various manufacturing processes. By consolidating multiple specialized instruments into one multi-functional robotic system, scheduling conflicts are eliminated as there is no longer competition for the same instrument, and automation is maintained across all operations.
Solution Approach 2:
Multiple separate automated instruments that previously caused scheduling conflicts are merged into a single robotic cluster. This consolidation integrates previously separate automation systems into one coordinated unit, reducing scheduling complexity while maintaining high automation levels across all manufacturing operations.
3Manufacturing precision
If manual handling and double-checking processes are used, then precision is maintained for sensitive cells, but time consumption and potential human errors increase
Solution Approach 1:
The robotic cluster performs self-verification through programmable sequences, automatically executing and verifying each step of the manufacturing process without requiring manual double-checking. This maintains precision through consistent automated execution while eliminating the time loss associated with manual verification steps.
Solution Approach 2:
The automated robotic system executes manufacturing operations continuously without the interruptions inherent in manual processes. The robotic cluster performs handling, connecting, and verification operations in continuous automated sequences, eliminating the time losses from manual task transitions and maintaining precision through uninterrupted automated execution.
Data Source
AI summary
Systems, methods, and devices for facilitating automated manufacture of one or more cellular therapies through a graphical user interface (GUI) are provided. A method includes displaying a plurality of objects, each associated with a unit operation to be performed by a robotic cluster of a biological foundry. The method also include selecting and organizing desired objects to generate a representation of a workflow for the robotic cluster(s) to produce some or all of a cellular therapy. The representation of a workflow can be saved, retrieved and/or modified to generate an updated representation of the workflow.


